Literature DB >> 11955596

Structural basis of T cell recognition of peptides bound to MHC molecules.

Jia-huai Wang1, Ellis L Reinherz.   

Abstract

Helper T lymphocytes play a critical role in immune system activation following recognition of MHC class II-bound peptide ligands (pMHCII). These CD4 T cells stimulate B cell antibody production and cytolytic T cell generation. Until recently, the structural basis of coordinate T cell receptor (TCR) and CD4 co-receptor interaction with a given pMHCII was unknown. Here we review current structural data on specific pMHCII recognition by T cells and compare TCR and co-receptor docking to pMHCI versus pMHCII ligands. The implications of these findings for thymic selection, helper versus cytolytic T cell recognition and alloreactivity are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955596     DOI: 10.1016/s0161-5890(02)00033-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  27 in total

1.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

Authors:  Pedro A Reche; John-Paul Glutting; Hong Zhang; Ellis L Reinherz
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

2.  Divergent patterns of selection on the DAB and DXB MHC class II loci in Xiphophorus fishes.

Authors:  Kyle Summers; Kelly E Roney; Jack da Silva; Gerald Capraro; Brandon J Cuthbertson; Steven Kazianis; Gil G Rosenthal; Michael J Ryan; Thomas J McConnell
Journal:  Genetica       Date:  2008-07-04       Impact factor: 1.082

3.  Characterization of a non-classical MHC class II gene in the vulnerable Chinese egret (Egretta eulophotes).

Authors:  Wei Lei; Wenzhen Fang; Qingxian Lin; Xiaoping Zhou; Xiaolin Chen
Journal:  Immunogenetics       Date:  2015-06-02       Impact factor: 2.846

Review 4.  TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.

Authors:  Jon A Weidanz; Oriana Hawkins; Bhavna Verma; William H Hildebrand
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

5.  A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.

Authors:  Angelika B Riemer; Derin B Keskin; Guanglan Zhang; Maris Handley; Karen S Anderson; Vladimir Brusic; Bruce Reinhold; Ellis L Reinherz
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

Review 6.  Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.

Authors:  Matjaz Jeras; Irena Bricl; Robert Zorec; Urban Svajger
Journal:  J Biomed Biotechnol       Date:  2010-03-10

7.  MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles.

Authors:  Guang Lan Zhang; David S DeLuca; Derin B Keskin; Lou Chitkushev; Tanya Zlateva; Ole Lund; Ellis L Reinherz; Vladimir Brusic
Journal:  J Immunol Methods       Date:  2010-12-02       Impact factor: 2.303

8.  HLA class II allele polymorphism in an outbreak of chikungunya fever in Middle Andaman, India.

Authors:  Itta Krishna Chaaithanya; Nagarajan Muruganandam; Maile Anwesh; Reesu Rajesh; Sruti R Ghosal; Chinnaiah Kartick; Kadiyala Nageswara Prasad; Karuppiah Muthumani; Paluru Vijayachari
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

9.  HLA polymorphism and risk of multiple myeloma.

Authors:  Meral Beksac; Loren Gragert; Stephanie Fingerson; Martin Maiers; Mei-Jie Zhang; Mark Albrecht; Xiaobo Zhong; Wendy Cozen; Angela Dispenzieri; Sagar Lonial; Parameswaran Hari
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

10.  Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.

Authors:  Rebecca A Harris; Kazushi Sugimoto; David E Kaplan; Fusao Ikeda; Malek Kamoun; Kyong-Mi Chang
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.